Cyanvac Llc

This study is testing a new COVID-19 vaccine given as a single spray into the nose. Researchers want to see if it is safe and if it triggers a good immune response against the virus. The trial will include up to 400 healthy adults aged 18 to 80, some of whom have had prior COVID …

This study is testing a new COVID-19 vaccine given as a single spray in the nose. It will compare this nasal spray to the currently approved mRNA shot to see if it is as safe and effective at preventing symptomatic COVID-19. The trial will enroll about 434 healthy adults and foll…

This early-stage trial is testing two new mumps vaccines given as a nasal spray. The main goal is to see if they are safe and can trigger an immune response in healthy adults who were vaccinated as children. Up to 60 participants will receive one dose of either vaccine or a place…